↓ Skip to main content

Cancer Cytogenetics

Overview of attention for book
Cover of 'Cancer Cytogenetics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cancer Cytogenetics: An Introduction.
  3. Altmetric Badge
    Chapter 2 Chromosome Preparation for Myeloid Malignancies.
  4. Altmetric Badge
    Chapter 3 Chromosome Preparation for Acute Lymphoblastic Leukemia.
  5. Altmetric Badge
    Chapter 4 Chromosome Preparation for Chronic Lymphoid Malignancies.
  6. Altmetric Badge
    Chapter 5 Cytogenetic Harvesting of Cancer Cells and Cell Lines.
  7. Altmetric Badge
    Chapter 6 Chromosome Bandings.
  8. Altmetric Badge
    Chapter 7 Chromosome Recognition.
  9. Altmetric Badge
    Chapter 8 Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
  10. Altmetric Badge
    Chapter 9 Fluorescence In Situ Hybridization Probe Preparation.
  11. Altmetric Badge
    Chapter 10 Fluorescence In Situ Hybridization Probe Validation for Clinical Use.
  12. Altmetric Badge
    Chapter 11 Fluorescence In Situ Hybridization on Tissue Sections.
  13. Altmetric Badge
    Chapter 12 Cytoplasmic Immunoglobulin Light Chain Revelation and Interphase Fluorescence In Situ Hybridization in Myeloma.
  14. Altmetric Badge
    Chapter 13 Quantitative Fluorescence In Situ Hybridization (QFISH).
  15. Altmetric Badge
    Chapter 14 High Resolution Fiber-Fluorescence In Situ Hybridization.
  16. Altmetric Badge
    Chapter 15 Array-Based Comparative Genomic Hybridization (aCGH).
  17. Altmetric Badge
    Chapter 16 Multicolor Karyotyping and Fluorescence In Situ Hybridization-Banding (MCB/mBAND).
  18. Altmetric Badge
    Chapter 17 Cytogenetics for Biological Dosimetry.
  19. Altmetric Badge
    Chapter 18 Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
  20. Altmetric Badge
    Chapter 19 Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.
  21. Altmetric Badge
    Chapter 20 Recurrent Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Chronic Myeloid Leukemia.
  22. Altmetric Badge
    Chapter 21 Recurrent Cytogenetic Abnormalities in Acute Lymphoblastic Leukemia.
  23. Altmetric Badge
    Chapter 22 Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
  24. Altmetric Badge
    Chapter 23 Recurrent Cytogenetic Abnormalities in Multiple Myeloma.
  25. Altmetric Badge
    Chapter 24 Cytogenetic Nomenclature and Reporting.
  26. Altmetric Badge
    Chapter 25 Cytogenetic Resources and Information.
Attention for Chapter 8: Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Chapter number 8
Book title
Cancer Cytogenetics
Published in
Methods in molecular biology, January 2017
DOI 10.1007/978-1-4939-6703-2_8
Pubmed ID
Book ISBNs
978-1-4939-6701-8, 978-1-4939-6703-2
Authors

Montakarn Tansatit

Editors

Thomas S.K. Wan

Abstract

The molecular characterization of nonrandom recurrent cytogenetic abnormalities has identified numerous disease-related genes involved in hematologic and lymphoid malignancies. Cytogenetic analysis has become essential for disease diagnosis, classification, prognostic stratification, and treatment guidance. Fluorescence in situ hybridization (FISH) has greatly enhanced the field and enabled a more precise determination of the presence and frequency of genetic abnormalities. The advantages of FISH compared to standard cytogenetic analysis are that FISH can be used to identify genetic changes that are too small to be detected under a microscope, does not require cell culture, and can be applied directly on fresh or paraffin-embedded tissues for rapid evaluation of interphase nuclei. The application of FISH with a variety of chromosome-specific DNA probes helps to further define molecular subclasses and cytogenetic risk categories for patients with particular hematologic malignancies. FISH analysis is useful in identifying genetic abnormalities undetectable by conventional chromosomal analysis and monitoring residual disease during treatment and follow-up. Therefore, FISH has become an indispensable tool in the management of hematologic malignancies.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 20%
Student > Master 3 15%
Librarian 1 5%
Other 1 5%
Lecturer > Senior Lecturer 1 5%
Other 4 20%
Unknown 6 30%
Readers by discipline Count As %
Medicine and Dentistry 6 30%
Biochemistry, Genetics and Molecular Biology 4 20%
Unspecified 1 5%
Social Sciences 1 5%
Business, Management and Accounting 1 5%
Other 0 0%
Unknown 7 35%